Here is what the math looks like for the people who regret it: $10,000 spent on both knees. Zero improvement — or worse, more pain. It happens more than clinic websites suggest.
It also happens that someone with moderate knee osteoarthritis — grade 2–3, not bone-on-bone — gets two years of significantly reduced pain and delays a joint replacement they were dreading. Same treatment category. Very different outcomes.
Cost is only one number. Candidacy and provider quality determine what you actually get for it. This page covers the cost. For whether it makes sense for your specific situation, read our evidence and candidacy guide →
All orthopedic stem cell procedures are cash-pay. Medicare and private insurance do not cover them. No exceptions for any orthopedic indication in 2026.
Price range reported by patients in The Niche (UC Davis, Prof. Paul Knoepfler) polling, late 2025. The $20,000+ range was the second-most-reported answer — both knees or multi-joint protocols drive costs higher.
The procedure type is the biggest cost driver — and also the biggest quality driver. Not all stem cell products are the same.
Two patients can each be told they received "stem cell therapy for their knee" and pay anywhere from $3,500 to $12,000. These are the five variables that drive that gap — and not all of them are obvious:
Autologous vs. donor product
Procedures using your own bone marrow or fat tissue require a draw, same-day processing, and more physician time. Amniotic and cord blood products are off-the-shelf — faster to administer, often cheaper, but the FDA and independent analyses have consistently found they contain few viable cells.
Image guidance
Ultrasound or fluoroscopy-guided injections place cells precisely at the target site. Unguided injections are faster and cheaper — and have meaningfully worse outcomes. Some providers include imaging in their quote; others bill it separately.
Provider type and training
An orthopedic surgeon or sports medicine physician with fellowship training in regenerative medicine will typically charge more than a chiropractor or urgent care clinic offering stem cell injections as an add-on. That cost difference often reflects real differences in technique and patient selection.
Geography
California, New York, and Florida clinics typically price higher than the national average. The same BMAC procedure can run $4,500 in a mid-size Midwest city and $9,000 in Los Angeles.
Protocol complexity
Some providers use a single injection; others use multi-point injection protocols or series treatments. A published outcomes study may have used three injection sessions — ask whether the protocol you're quoted matches what the data was based on.
These are ranges across U.S. providers, not quotes. Your actual cost depends on procedure type, imaging, and provider.
The headline procedure price is often not the total cost. These line items are real — and frequently omitted from initial quotes.
No. Not Medicare. Not Medicaid. Not private insurance. No orthopedic indication.
The FDA has not approved any stem cell product for orthopedic use. That regulatory status means insurers classify these procedures as experimental and exclude them from coverage. This applies even when your physician believes the treatment is clinically appropriate.
Some patients use HSA or FSA funds. Financing through CareCredit or similar medical lending is common. A small number of providers offer payment plans — ask directly. But there is no insurance path for orthopedic regenerative medicine in 2026.
These are the questions patients most commonly wish they had asked before committing.
What is included in the quoted price — imaging guidance, processing fees, and any follow-up injections?
Is this price per joint or per session? If I have two knees treated, is there a separate charge?
Do you use my own cells (autologous) or a processed donor product?
What is your retreatment protocol if I don't improve — and what does that cost?
What outcomes data do you track for patients like me, and can I see it?
Also worth reading
The patients who regret the expense are disproportionately people who were not good candidates — bone-on-bone OA, complete tears, or unrealistic expectations set by a clinic's marketing. Before budgeting for the procedure, confirm whether your condition is a realistic indication.
Read the evidence and candidacy guide →Every provider in the RegenSelect directory has been verified for an active orthopedic or sports medicine practice. No paid placements. No unverified listings.